Atrial Fibrillation Ablation Device Comparison Study
Randomized Comparison of Ablation Devices Used During Surgery for the Treatment of Atrial Fibrillation
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Atrial fibrillation is an irregular heart rhythm which requires long term anticoagulation to prevent risk of stroke and long term poor outcomes. At the same time one have heart surgery, a small additional procedure can be done to treat atrial fibrillation. Surgeons have a choice of six different devices that he or she can use to treat your atrial fibrillation. It is not known at this point which device is best at treating you, as each device seems to have the same success rate at curing atrial fibrillation. One of the six devices will be selected randomly by card pulled out at the time of enrollment. It is therefore the purpose of this study to compare the devices to each other and to follow up after surgery to determine if any one device is best. This information will be valuable to surgeons and to patients as the treatment for atrial fibrillation develops in the future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
April 25, 2007
CompletedFirst Posted
Study publicly available on registry
April 27, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2009
CompletedAugust 17, 2018
August 1, 2018
1.6 years
April 25, 2007
August 15, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Freedom from Atrial fibrillation
No atrial fibrillation noted by standard testing (Spot ECG, history, 24-hour Holter recording, Cardiac MRI or echocardiogram, Brain Natriuretic Peptide (BNP) levels
3 months after surgery
Rhythm at 12 months
No atrial fibrillation noted by standard testing (Spot ECG, history, 24-hour Holter recording, Cardiac MRI or echocardiogram, BNP levels
12 months after surgery
Major Adverse Cardiovascular Events (MACEs) at 1 and 3 months
Recording any major adverse cardiovascular events reported
1 and 3 months post-surgical procedure
Secondary Outcomes (3)
Functional and qualitative improvement in heart failure, ejection fraction, left atrial size, exercise tolerance
6 and 12 months post-surgical procedure
Rhythm at 3, 6 and 9 months
3, 6 and 9 months post-surgical procedure
All other adverse events
From surgical procedure through 12 months follow-up
Study Arms (6)
Dry bipolar radiofrequency (RF) clamp
ACTIVE COMPARATORused for ablation during surgical procedure
Unipolar microwave antenna
ACTIVE COMPARATORused for ablation during surgical procedure
Unipolar cryothermic probe
ACTIVE COMPARATORused for ablation during surgical procedure
Irrigated unipolar RF antenna
ACTIVE COMPARATORused for ablation during surgical procedure
Irrigated bipolar RF clamp
ACTIVE COMPARATORused for ablation during surgical procedure
Hi-intensity focused ultrasound wand
ACTIVE COMPARATORused for ablation during surgical procedure
Interventions
Specified device used for ablation during standard surgical procedure
Specified device used for ablation during standard surgical procedure
Specified device used for ablation during standard surgical procedure
Specified device used for ablation during standard surgical procedure
Specified device used for ablation during standard surgical procedure
Specified device used for ablation during standard surgical procedure
Eligibility Criteria
You may qualify if:
- All patients undergoing concomitant cardiac surgery who also have AF.
You may not qualify if:
- Patients undergoing re-do or emergency procedures
- Females of child-bearing age who are pregnant
- Age less than 19 and more than 75 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maimonides Medical Center
Brooklyn, New York, 11219, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adam E Saltman, MD
Director Atrial fibrillation Program, Cardiothoracic Surgeon
- PRINCIPAL INVESTIGATOR
Kamran B Ali, MD
Cardiology Fellow
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2007
First Posted
April 27, 2007
Study Start
April 1, 2007
Primary Completion
November 20, 2008
Study Completion
May 1, 2009
Last Updated
August 17, 2018
Record last verified: 2018-08